trofosfamide has been researched along with Cancer of Ovary in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (33.33) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (66.67) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Hartmann, JT; Kanz, L; Kopp, HG | 1 |
| Gastl, G; Gierlich, T; Gunsilius, E; Mross, K; Unger, C | 1 |
| Franz, G; Lietz, H | 1 |
1 trial(s) available for trofosfamide and Cancer of Ovary
| Article | Year |
|---|---|
[Results of the Hamburg ovarian blastoma study].
Topics: Antineoplastic Combined Chemotherapy Protocols; Clinical Trials as Topic; Combined Modality Therapy; Cyclophosphamide; Female; Fluorouracil; Germany, West; Humans; Ifosfamide; Melphalan; Methotrexate; Neoplasm Staging; Ovarian Neoplasms; Prognosis; Random Allocation; Tegafur; Vincristine | 1985 |
2 other study(ies) available for trofosfamide and Cancer of Ovary
| Article | Year |
|---|---|
Complete remission of relapsing high-grade angiosarcoma with single-agent metronomic trofosfamide.
Topics: Administration, Oral; Antineoplastic Agents, Alkylating; Cyclophosphamide; Female; Hemangiosarcoma; Humans; Middle Aged; Neoplasm Recurrence, Local; Ovarian Neoplasms; Remission Induction | 2006 |
Palliative chemotherapy in pretreated patients with advanced cancer: oral trofosfamide is effective in ovarian carcinoma.
Topics: Adult; Aged; Antineoplastic Agents, Alkylating; Cyclophosphamide; Female; Humans; Male; Middle Aged; Ovarian Neoplasms; Palliative Care; Retrospective Studies | 2001 |